New Takeda R&D Collabs Aim To Boost IO Pipeline

In moves aimed at boosting its presence in the immuno-oncology field, Takeda unveils a series of new research collaborations it believes will lead to pipeline gains in this critical field over the next few years.

3D illustration of T cells attacking a cancer cell (CAR-T cell therapy) - Illustration
Takeda Boosts IO Activities Through Alliances • Source: Shutterstock

More from Anticancer

More from Therapy Areas